Supernus Pharmaceuticals, Inc. (SUPN)
NASDAQ: SUPN · Real-Time Price · USD
46.84
+2.09 (4.67%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Supernus Pharmaceuticals Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Supernus Pharmaceuticals stock have an average target of 63.17, with a low estimate of 55 and a high estimate of 66. The average target predicts an increase of 34.86% from the current stock price of 46.84.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Supernus Pharmaceuticals stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $66 | Buy | Maintains | $66 | +40.91% | Jun 4, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Hold Maintains $55 | Hold | Maintains | $55 | +17.42% | May 6, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $65 | Buy | Maintains | $65 | +38.77% | May 6, 2026 |
Unknown Analyst Jefferies No rating | Jefferies | Buy Maintains $60 → $65 | Buy | Maintains | $60 → $65 | +38.77% | Mar 24, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $65 | Buy | Maintains | $65 | +38.77% | Feb 25, 2026 |
Financial Forecast
Revenue This Year
867.26M
from 718.95M
Increased by 20.63%
Revenue Next Year
1.02B
from 867.26M
Increased by 17.60%
EPS This Year
2.49
from 2.40
Increased by 3.82%
EPS Next Year
4.34
from 2.49
Increased by 74.66%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 872.5M | 1.0B | |
| Avg | 867.3M | 1.0B | |
| Low | 859.0M | 996.3M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 21.4% | 20.3% | |
| Avg | 20.6% | 17.6% | |
| Low | 19.5% | 14.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | 2.49 | 4.34 | |
| Low | - | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | 3.8% | 74.7% | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.